239 results
Page 6 of 12
425
woxy5f5y
17 Jun 22
Business combination disclosure
4:03pm
8-K
n1p50u9zdhb0x5zw4n
17 Jun 22
Kineta Presents New Preclinical Data and Phase 1/2 Clinical Trial Design of KVA12.1 at the Tumor Myeloid-Directed Therapies Summit
4:02pm
425
ob3roq
6 Jun 22
Business combination disclosure
4:05pm
8-K
EX-2.7
6zo7rf18u p2cr9wejj
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-2.5
obn8udrw
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-2.6
e6kf1c3ud15ok5
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-2.1
wi40pavf
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-2.2
7p3r bh03
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
nfc1kgm4 3b6s3d76l1b
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-2.4
f57uu t993x
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-2.3
ept3eyz7061nfm3ze6yj
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-10.1
0fsowqtybptai
4 Mar 22
Entry into a Material Definitive Agreement
4:15pm